2021
- Medicines Australia thanks Minister Hunt Thursday, 2 December 2021
- Strengthening patient access to new medicines through new landmark Bill Thursday, 2 December 2021
- Medicines Australia welcomes tabling of parliamentary report about approval processes for new drugs and novel medical technologies Thursday, 25 November 2021
- New members of the Medicines Australia Advisory Council Wednesday, 27 October 2021
- Pharmaceutical industry backs workplace vaccinations Tuesday, 5 October 2021
- Medicines industry continues to protect Australians from medicine shortages Thursday, 30 September 2021
- Medicines Australia and AusBiotech say COVID-19 vaccine patent waiver will not speed up global vaccination Wednesday, 15 September 2021
- Joint Statement of support for an Australian Patent Box Monday, 13 September 2021
- Leap forward for patients accessing medicines Tuesday, 7 September 2021
- Statement on Moderna COVID-19 vaccine Monday, 6 September 2021
- COVID-19 vaccine claims scheme Sunday, 29 August 2021
- National Medicines Policy Review will be significant for all Australians Friday, 30 July 2021
- Clinical trial national approach will benefit patients and our economy Tuesday, 20 July 2021
- Aboriginal and Torres Strait Islander Medicines Committee launches during NAIDOC Week Wednesday, 7 July 2021
- Moving patient stories highlight opportunities to strengthen our healthcare systems for all Australians Thursday, 24 June 2021
- Prestigious event at Parliament House will ‘make room for the patient view’ Friday, 18 June 2021
- Industry and Health Consumer Organisations working together Monday, 7 June 2021
- CEO initial reactions to 2021 Federal Budget – VIDEO Thursday, 13 May 2021
- 2021-22 FEDERAL BUDGET: Health Front and Centre of Economic Recovery Tuesday, 11 May 2021
- Strategic Agreement Statement – Medicines Australia – The Government and Medicines Australia jointly agree to finalise patient-centric Strategic Agreement after the Budget Saturday, 8 May 2021
- Medicines Australia updated position on Intellectual Property (in light of TRIPS Waiver) Thursday, 6 May 2021
- Medicines Australia position on Intellectual Property (in light of TRIPS Waiver) Friday, 30 April 2021
- Investment in innovative medicines needed to safeguard Australia’s long-term prosperity Sunday, 21 March 2021
- CEO Interview with Sky News Thursday, 18 March 2021
- Medicines Australia welcomes Day 1 of Australia’s vaccination rollout Monday, 22 February 2021
- Medicines Australia’s Statement on Anti-vax Protests Saturday, 20 February 2021
- Medicines Australia’s Statement on the arrival of the Pfizer Vaccine Wednesday, 17 February 2021
- Medicines Australia Statement on TGA’s provisional approval of AstraZeneca’s COVID-19 vaccine Tuesday, 16 February 2021
- Medicines Australia’s position on potential European Union restrictions and vaccines supply Saturday, 30 January 2021